Microbot Medical (FRA:CY9D) OCF Margin %: -4,803.30% (As of Mar. 2026)

What is Microbot Medical OCF Margin %?

Microbot Medical FRA:CY9D +0.64% 29 OCF Margin % is -4,803.30% as of Mar. 2026. GuruFocus rates FRA:CY9D with a GF Score™ of 29/100. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Microbot Medical ranks worse than 98.77% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Microbot Medical's Cash Flow from Operations for the three months ended in Mar. 2026 was €-4.37 Mil. Microbot Medical's Revenue for the three months ended in Mar. 2026 was €0.09 Mil. Therefore, Microbot Medical's OCF Margin % for the quarter that ended in Mar. 2026 was -4,803.30%.

As of today, Microbot Medical's current OCF Yield % is -12.63%.

The historical rank and industry rank for Microbot Medical's OCF Margin % or its related term are showing as below:

FRA:CY9D' s OCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: -14378.02

FRA:CY9D's OCF Margin % is ranked worse than
98.77% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs FRA:CY9D: -14378.02

Microbot Medical OCF Margin % Related Terms

Microbot Medical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Microbot Medical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbot Medical OCF Margin % Chart

Microbot Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

0.00

Microbot Medical Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	-4,803.30

FRA:CY9D vs KRMD, STXS, EMBC: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Microbot Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbot Medical OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Microbot Medical's OCF Margin % falls into.

Save Embed

29GF Score

Microbot Medical Inc FRA:CY9D

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Microbot Medical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Microbot Medical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-11.141	/	0
	=	%

Microbot Medical's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-4.371	/	0.091
	=	-4,803.30 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -4,803.30% mean?

Microbot Medical (FRA:CY9D) has a OCF Margin % of -4,803.30% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Microbot Medical and its competitors. According to the industry distribution chart, Microbot Medical ranks #805 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 98.8%.

Is Microbot Medical's OCF Margin % too high?

Microbot Medical's current OCF Margin % is -4,803.30%. Based on the distribution chart, Microbot Medical ranks #805 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Microbot Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.

How does Microbot Medical's OCF Margin % compare to KRMD and STXS?

According to the Medical Devices & Instruments industry distribution chart, Microbot Medical ranks #805 out of 815 companies for OCF Margin %. This places Microbot Medical in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Medical Devices & Instruments company?

The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Microbot Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbot Medical's current OCF Margin % is -4,803.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Microbot Medical stock overvalued right now?

Microbot Medical (FRA:CY9D) has a current OCF Margin % of -4,803.30%. The current OCF Margin % is -4,803.30%. Microbot Medical's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Microbot Medical (FRA:CY9D), the current OCF Margin % is -4,803.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microbot Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies KRMD STXS EMBC PDEX SMTI UTMD DXR POCI NEPH MLSS ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges MBOT:USA

Address 175 Derby Street, Building 27, Hingham, MA, USA, 02043

Website https://www.microbotmedical.com

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

29GF Score

Get the complete analysis for FRA:CY9D

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.57

Price

View FRA:CY9D Analysis

See OCF Margin % data for all stocks →